GlassScriptPhysician profile
Vincent J Lang
NPI 1083672620
$12,473.58
in general payments reported to CMS, 2019-2025
51 companies · $2,956 in 2025
The $2,956 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,448 · 2020: $323 · 2021: $504 · 2022: $1,835 · 2023: $2,628 · 2024: $2,780 · 2025: $2,956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,363.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,110.60 | 2019-2025 | |
| Novo Nordisk INC | $1,235.26 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $982.07 | 2019-2025 | Repatha, Evenity, Otezla |
| Pfizer INC. | $948.16 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $661.33 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $626.57 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $522.18 | 2019-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $398.37 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Phathom Pharmaceuticals, INC. | $379.47 | 2023-2025 | Voquezna |
| Mylan Specialty L.P. | $359.02 | 2022-2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $346.22 | 2019-2025 | Spravato |
| Novartis Pharmaceuticals Corporation | $336.43 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $326.15 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $272.00 | 2019-2025 | Verquvo, Belsomra, Lagevrio |
| Exact Sciences Corporation | $228.42 | 2023-2025 | Cologuard Collection Kit |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $195.28 | 2022-2025 | Nexletol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $179.32 | 2024-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $165.48 | 2019-2025 | Trintellix |
| Biohaven Pharmaceutical Holding Company LTD. | $150.39 | 2022 | |
| Kerecis Limited | $150.00 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bausch Health US, LLC | $147.80 | 2019-2025 | Aplenzin, Wellbutrin |
| Dynavax Technologies Corporation | $144.62 | 2024-2025 | Heplisav-B |
| Biohaven Pharmaceuticals, INC. | $135.39 | 2021 | |
| Azurity Pharmaceuticals, INC. | $130.39 | 2023-2025 | Edarbi, Azmiro, Edarbi |
| Paratek Pharmaceuticals, INC. | $115.53 | 2024-2025 | Nuzyra, Xhance |
| Idorsia Pharmaceuticals US INC | $107.50 | 2023-2024 | Quviviq |
| Amarin Pharma, INC. | $101.97 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $98.89 | 2019-2022 | |
| Astellas Pharma US INC | $91.03 | 2019-2025 | Veozah |
| Viatris Specialty LLC | $88.47 | 2025 | Yupelri |
| Corcept Therapeutics | $68.80 | 2024 | Korlym |
| Abbott Laboratories | $67.55 | 2023-2024 | Freestyle Libre 3, Freestyle Libre |
| Kowa Pharmaceuticals America, INC. | $56.42 | 2021-2025 | Zoryve |
| Radius Health, INC. | $55.17 | 2024-2025 | Tymlos |
| Axsome Therapeutics, INC. | $53.32 | 2025 | Auvelity |
| Sanofi-Aventis U.S. LLC | $47.98 | 2021-2023 | |
| Arbor Pharmaceuticals, INC. | $47.26 | 2019-2022 | |
| Allergan, INC. | $41.96 | 2019 | |
| Urgo Medical North America, LLC | $37.87 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Antares Pharma, INC. | $34.51 | 2025 | Xyosted |
| Aytu Biopharma, INC. | $33.87 | 2019 | |
| Alfasigma USA, INC. | $31.13 | 2020-2021 | |
| Philips North America LLC | $29.26 | 2021-2024 | (Ak6) Vest Therapy |
| Convatec INC. | $23.59 | 2023 | |
| Tolmar, INC. | $19.17 | 2025 | Jatenzo |
| Nevro Corp. | $18.79 | 2024 | Senza |
| Biodelivery Sciences International, INC. | $18.53 | 2019 | |
| Ironshore Pharmaceuticals INC. | $15.78 | 2019 | |
| Verity Pharmaceuticals INC. | $14.45 | 2024 | Tlando |
| Genentech USA, INC. | $12.63 | 2019 | |
| Sanofi Pasteur INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.